Evolution of extravascular implantable defibrillator technologies.
Modular cardiac rhythm management system
S-ICD
Subcutaneous implantable cardioverter-defibrillator
Substernal lead
Ventricular arrhythmias
Journal
Progress in cardiovascular diseases
ISSN: 1873-1740
Titre abrégé: Prog Cardiovasc Dis
Pays: United States
ID NLM: 0376442
Informations de publication
Date de publication:
Historique:
received:
15
04
2019
accepted:
15
04
2019
pubmed:
21
4
2019
medline:
8
10
2019
entrez:
21
4
2019
Statut:
ppublish
Résumé
The implantable cardioverter-defibrillator (ICD) has been successfully treating patients with lethal ventricular arrhythmias for decades. The main acute and chronic complications of this therapy modality are related to the use of a transvenous lead. An entirely extravascular ICD concept was developed over the last 20 years, with emergence of the subcutaneous ICD (S-ICD). This device was approved for clinical use seven years ago, and accumulating real-life experience confirms its safety and efficacy. The main limitations related to this system include the lack of pacing capabilities for bradycardia, tachycardia or resynchronization therapy, a large size, and relatively high energy requirements for effective defibrillation. This review article summarizes current knowledge and potential future developments of the extravascular ICD technologies.
Identifiants
pubmed: 31004606
pii: S0033-0620(19)30071-4
doi: 10.1016/j.pcad.2019.04.003
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
249-255Informations de copyright
Copyright © 2019 Elsevier Inc. All rights reserved.